Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
Go back to Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System| Johnson & Johnson (NYSE: JNJ) | Delayed: 259.27 +3.64 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.63 | 52 Week High | $126.07 | |||
| Open | $255.24 | 52 Week Low | $94.28 | |||
| Day High | $260.20 | P/E | 53.90 | |||
| Day Low | $254.42 | EPS | $4.81 | |||
| Volume | 8,063,714 | |||||
